RHUMBLINE ADVISERS - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,029,524
-21.4%
47,487
+0.8%
0.01%
-18.2%
Q2 2023$10,216,454
+127845.6%
47,113
+7.2%
0.01%
+10.0%
Q1 2023$7,985
-3.3%
43,958
+4.6%
0.01%
-9.1%
Q4 2022$8,261
-99.9%
42,041
+4.8%
0.01%
-15.4%
Q3 2022$9,023,000
+129.6%
40,113
+29.1%
0.01%
+116.7%
Q2 2022$3,930,000
+34.3%
31,065
+34.6%
0.01%
+50.0%
Q1 2022$2,926,000
-0.3%
23,080
+3.0%
0.00%0.0%
Q4 2021$2,936,000
+6.0%
22,411
-1.1%
0.00%0.0%
Q3 2021$2,771,000
+10.0%
22,650
+2.4%
0.00%
+33.3%
Q2 2021$2,520,000
+14.2%
22,111
+20.5%
0.00%0.0%
Q1 2021$2,207,000
+8.7%
18,355
-8.2%
0.00%0.0%
Q4 2020$2,031,000
+32.7%
19,988
+1.0%
0.00%
+50.0%
Q3 2020$1,531,000
-39.8%
19,798
-13.3%
0.00%
-50.0%
Q2 2020$2,544,000
+153.1%
22,827
+63.6%
0.00%
+100.0%
Q1 2020$1,005,000
+165.9%
13,957
+178.4%
0.00%
+100.0%
Q4 2019$378,0005,0140.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders